Welcome to the forefront of prostate health knowledge! Today, we are thrilled to introduce an eminent expert who will guide us through a labyrinth of cutting-edge advancements and breakthroughs in the field of urology! Dr. Kelly Stratton is a board-certified urologist with a profound passion for enhancing the well-being of individuals through cutting-edge advancements. His expertise shines through his roles as an assistant professor of urologic oncology at the esteemed OU Department of Urology in Oklahoma City, Oklahoma, and as an Adjunct Assistant Professor of Medical Oncology at the prestigious Stevenson Cancer Center. His exceptional training at the renowned Memorial Sloan Kettering Cancer Center in New York and residency at Vanderbilt University Medical Center in Nashville, Tennessee, further underscore his profound knowledge and experience in the field. With a focus on leveraging innovative technologies such as MRI to revolutionize prostate cancer biopsy and detection, Dr. Stratton shows his commitment to personalized care by utilizing genomic testing and participating in groundbreaking clinical trials. In today's episode, we delve into a critical aspect of prostate cancer treatment: exploring the available salvage options when the initial treatment fails. Whether you are contemplating your treatment choices or have already undergone radiation therapy for prostate cancer, this episode is a must-listen! Prepare to be inspired and informed as we explore the forefront of prostate health under the guidance of Dr. Kelly Stratton! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: What is the most frequent way PSA recurrence gets evaluated? The challenges Dr. Stratton experiences when identifying radiation failure patients What patients can expect in the evaluation for recurrent prostate cancer The factors Dr. Stratton considers in his practice when determining whether or not a patient is a good candidate for salvage treatment Dr. Stratton discusses treatment options for patients with PSA recurrence after radiation Risks associated with radiation therapy Salvage treatment options How do salvage treatment options continue to evolve? Dr. Stratton discusses fusion and targeted biopsies. What is the success rate for treatment after radiation therapy? Join us today as we navigate the landscape of post-radiation therapy scenarios. Dr. Stratton shares valuable insights and guidance for those seeking alternative approaches and sheds light on the most frequent way PSA recurrence gets evaluated, the challenges in identifying radiation failure patients, evaluation for recurrent prostate cancer, factors determining eligibility for salvage treatment, treatment options, risks associated with radiation therapy, evolving salvage treatment options, fusion and targeted biopsies, and success rates for treatment after radiation therapy. Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd Get your free What To Expect Guide (or find the link on our podcast website) Join our Facebook group Follow Dr. Pohlman on Twitter and Instagram Go to the Prostate Health Academy to sign up. You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. OU Health- Dr. Kelly Stratton

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related